Full View

Efficacy and tolerability of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus

KB Harris, DJ McCarty - Therapeutic Advances in …, 2015 - journals.sagepub.com
Glucagon-like peptide-1 (GLP-1) has been evaluated for use in the treatment of type 2
diabetes mellitus (T2DM) due to its role in glucose regulation. Four GLP-1 receptor agonists …
被引用次数：87 相关文章

Efficacy and tolerability of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus

KB Harris, DJ McCarty - Therapeutic advances in …, 2015 - pubmed.ncbi.nlm.nih.gov
Glucagon-like peptide-1 (GLP-1) has been evaluated for use in the treatment of type 2
diabetes mellitus (T2DM) due to its role in glucose regulation. Four GLP-1 receptor agonists …
[HTML] nih.gov

[HTML][HTML] Efficacy and tolerability of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus

KB Harris, DJ McCarty - Therapeutic Advances in Endocrinology …, 2015 - ncbi.nlm.nih.gov
Abstract Glucagon-like peptide-1 (GLP-1) has been evaluated for use in the treatment of
type 2 diabetes mellitus (T2DM) due to its role in glucose regulation. Four GLP-1 receptor …

Efficacy and tolerability of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus.

KB Harris, DJ McCarty - Therapeutic Advances in Endocrinology …, 2015 - europepmc.org
Abstract Glucagon-like peptide-1 (GLP-1) has been evaluated for use in the treatment of
type 2 diabetes mellitus (T2DM) due to its role in glucose regulation. Four GLP-1 receptor …